PUBLIC CONTRACT · 2020

Medic. Atazanavir 200 mg, Cetorolac 30 mg, Folinato cálcio 300 mg

Contract value: €3,079.50
Signed on: 6 November 2020
Procedure: Ao abrigo de acordo-quadro (art.º 259.º)

This page lays out the fields published on Portal BASE and says when a field is unavailable. It is not an assessment of the contract's merit, legality or impact.

Record 10762082

PUBLISHED SUBJECT

41/4645/2020 - Medic. Atazanavir 200 mg, Cetorolac 30 mg, Folinato cálcio 300 mg

Parties involved

Contracting body: Centro Hospitalar Universitário do Algarve, E.P.E.
Awardee: HIKMA FARMACÊUTICA (PORTUGAL) SA.; GENERIS – FARMACEUTICA, S.A.
Place of performance: Portugal, Faro, Faro
NUTS region: PT150 - Algarve

WHO BID

Awardee and competitors

Companies that IMPIC lists as the awardee and as competitors in this procedure.

Awardee: HIKMA FARMACÊUTICA (PORTUGAL) SA. · Tax ID 502266791
Awardee: GENERIS – FARMACEUTICA, S.A. · Tax ID 508107997

Values and timeline

Contract price: €3,079.50
Procedure base price: €0.00
Total effective price: Not reported on Portal BASE
Publication date: 11 June 2024
Award date: 6 November 2020
Signing date: 6 November 2020
Performance period: 61 days

The contract price is the value agreed in the contract, not the amount paid.

Procedure and framework

Contract type: Aquisição de bens móveis
Procedure type: Ao abrigo de acordo-quadro (art.º 259.º)
Award criterion: Melhor relação qualidade – preço
CPV code: 33600000-6 - Produtos farmacêuticos
Legal basis: Artigo 259.º do Código dos Contratos Públicos
Regime: Código dos Contratos Públicos ( DL 111-B/2017 )
Framework agreement: CP 2019/55 - Medicamentos diversos
Centralised procedure: No
Environmental criterion: No
Notice: Not stated
Procedure identifier: 4886216

Compare with other contracts

Search the same body, supplier, place or type of service to understand the context of the published index.

← Back to contracts